ArticleInvestigational new drugs2021

Significant benefit of everolimus in a patient with urothelial bladder cancer harboring a rare M1043I mutation of PIK3CA.

Shouhua Pan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.